New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-06-08
DOI
10.3389/fphar.2017.00354
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- On the pathogenesis of mTOR inhibitor-associated stomatitis (mIAS)-studies using an organotypic model of the oral mucosa
- (2017) S Sonis et al. ORAL DISEASES
- A randomised controlled trial of Caphosol mouthwash in management of radiation-induced mucositis in head and neck cancer
- (2017) Kee H. Wong et al. RADIOTHERAPY AND ONCOLOGY
- Methylene Blue for the Treatment of Intractable Pain Associated with Oral Mucositis
- (2017) Carlos J. Roldan et al. Pain Practice
- CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC).
- (2017) Alan P. Venook et al. JOURNAL OF CLINICAL ONCOLOGY
- Oesophagus side effects related to the treatment of oesophageal cancer or radiotherapy of other thoracic malignancies
- (2016) Sonja Adebahr et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation
- (2016) Nathaniel Treister et al. BRITISH JOURNAL OF CANCER
- Irinotecan-induced mucositis: the interactions and potential role of GLP-2 analogues
- (2016) Bronwen J. Mayo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives
- (2016) Ronaldo A. Ribeiro et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements.
- (2016) Vitaliana De Sanctis et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial
- (2016) James A. Bonner et al. EUROPEAN JOURNAL OF CANCER
- Pharmacotherapy for the management of cancer regimen-related oral mucositis
- (2016) Alessandro Villa et al. EXPERT OPINION ON PHARMACOTHERAPY
- Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy
- (2016) Paolo Bossi et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Dusquetide: A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical study
- (2016) Mahesh Kudrimoti et al. JOURNAL OF BIOTECHNOLOGY
- Prevention of everolimus/exemestane (EVE/EXE) stomatitis in postmenopausal (PM) women with hormone receptor-positive (HR+) metastatic breast cancer (MBC) using a dexamethasone-based mouthwash (MW): Results of the SWISH trial.
- (2016) Hope S. Rugo et al. JOURNAL OF CLINICAL ONCOLOGY
- Host-Microbiome Cross-talk in Oral Mucositis
- (2016) R.M. Vasconcelos et al. JOURNAL OF DENTAL RESEARCH
- Efficacy of Sucralfate Mouth Wash in Prevention of 5-fluorouracil Induced Oral Mucositis: A Prospective, Randomized, Double-Blind, Controlled Trial
- (2016) Shahram Ala et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients
- (2016) Stephen T. Sonis et al. ORAL ONCOLOGY
- Cutaneous manifestations of nontargeted and targeted chemotherapies
- (2016) Veronica J. Shi et al. SEMINARS IN ONCOLOGY
- Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations
- (2016) Judith A. E. M. Zecha et al. SUPPORTIVE CARE IN CANCER
- Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy
- (2016) Youngjoo Kwon OncoTargets and Therapy
- Oral Cryotherapy for Preventing Oral Mucositis in Patients Receiving Cancer Treatment
- (2016) Philip Riley et al. JAMA Oncology
- A Novel Peptide for Simultaneously Enhanced Treatment of Head and Neck Cancer and Mitigation of Oral Mucositis
- (2016) Peili Chen et al. PLoS One
- Neutropenic Enterocolitis
- (2015) Taha Sachak et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up
- (2015) D. E. Peterson et al. ANNALS OF ONCOLOGY
- Incidence and Risk of High-grade Stomatitis with mTOR Inhibitors in Cancer Patients
- (2015) Raji Shameem et al. CANCER INVESTIGATION
- Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study
- (2015) Michal Mego et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Mucositis
- (2015) Alessandro Villa et al. CURRENT OPINION IN ONCOLOGY
- Antioxidant Supplementation on Cancer Risk and During Cancer Therapy: An Update
- (2015) Tomris Ozben CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Radiation induced oral mucositis: a review of current literature on prevention and management
- (2015) Supriya Mallick et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Caphosol® mouthwash gives no additional protection against oral mucositis compared to cryotherapy alone in stem cell transplantation. A pilot study
- (2015) Anncarin Svanberg et al. European Journal of Oncology Nursing
- S-1-based regimens and the risk of oral and gastrointestinal mucosal injury: a meta-analysis with comparison to other fluoropyrimidines
- (2015) Omar Abdel-Rahman et al. Expert Opinion On Drug Safety
- Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with everolimus, temsirolimus or ridaforolimus: a comparative systematic review and meta-analysis
- (2015) Omar Abdel-Rahman et al. Expert Review of Anticancer Therapy
- Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data
- (2015) Didier Meulendijks et al. LANCET ONCOLOGY
- Low-level laser therapy prevents severe oral mucositis in patients submitted to hematopoietic stem cell transplantation: a randomized clinical trial
- (2015) Betânia Ferreira et al. SUPPORTIVE CARE IN CANCER
- Treatment-related gastrointestinal toxicities and advanced colorectal or pancreatic cancer: A critical update
- (2015) Giuseppe Aprile WORLD JOURNAL OF GASTROENTEROLOGY
- Management of Mucositis During Chemotherapy: From Pathophysiology to Pragmatic Therapeutics
- (2015) Ysabella Z. A. Van Sebille et al. Current Oncology Reports
- Probiotics to prevent gastrointestinal toxicity from cancer therapy
- (2015) Matthew A. Ciorba et al. Current Opinion in Supportive and Palliative Care
- Gastrointestinal toxicities from targeted therapies
- (2015) Paolo Bossi et al. Current Opinion in Supportive and Palliative Care
- Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2
- (2014) H. S. Rugo et al. ANNALS OF ONCOLOGY
- Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer
- (2014) J. Y. Douillard et al. ANNALS OF ONCOLOGY
- Efficacy of benzydamine oral rinse in prevention and management of radiation-induced oral mucositis: A double-blind placebo-controlled randomized clinical trial
- (2014) Khosro M Sheibani et al. Asia-Pacific Journal of Clinical Oncology
- N-acetyl cysteine for prevention of oral mucositis in hematopoietic SCT: a double-blind, randomized, placebo-controlled trial
- (2014) A Moslehi et al. BONE MARROW TRANSPLANTATION
- Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck
- (2014) Ron R. Allison et al. CANCER
- MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
- (2014) Rajesh V. Lalla et al. CANCER
- Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy
- (2014) Dorothy M. Keefe et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Emerging therapies for the prevention and treatment of oral mucositis
- (2014) Anna Yuan et al. EXPERT OPINION ON EMERGING DRUGS
- Review of Preclinical Studies on Treatment of Mucositis and Associated Pain
- (2014) C.T. Viet et al. JOURNAL OF DENTAL RESEARCH
- The role of oral flora in the development of chemotherapy-induced oral mucositis
- (2014) Andrea M. Stringer et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
- (2014) Volker Heinemann et al. LANCET ONCOLOGY
- L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: A double-blind, randomized, placebo-controlled trial
- (2014) TAKAE TSUJIMOTO et al. ONCOLOGY REPORTS
- Phase II multicenter trial of Caphosol for the reduction of mucositis in patients receiving radiation therapy for head and neck cancer
- (2014) Nikhil G. Rao et al. ORAL ONCOLOGY
- Unanticipated frequency and consequences of regimen-related diarrhea in patients being treated with radiation or chemoradiation regimens for cancers of the head and neck or lung
- (2014) Stephen Sonis et al. SUPPORTIVE CARE IN CANCER
- Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy
- (2013) Sewanti Atul Limaye et al. CANCER
- Irinotecan disrupts tight junction proteins within the gut
- (2013) Hannah R Wardill et al. CANCER BIOLOGY & THERAPY
- Chronic radiation enteritis and malnutrition
- (2013) Gwilym James Webb et al. Journal of Digestive Diseases
- Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases
- (2013) Andrea M. Stringer et al. SUPPORTIVE CARE IN CANCER
- Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis
- (2013) Linda S. Elting et al. SUPPORTIVE CARE IN CANCER
- Emerging evidence on the pathobiology of mucositis
- (2013) Noor Al-Dasooqi et al. SUPPORTIVE CARE IN CANCER
- Changes in the Mucus Barrier during Cisplatin-Induced Intestinal Mucositis in Rats
- (2013) Hajime Yamamoto et al. Biomed Research International
- A Gastroenterologist's Guide to Probiotics
- (2012) Matthew A. Ciorba Clinical Gastroenterology and Hepatology
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- CXCL9 attenuated chemotherapy-induced intestinal mucositis by inhibiting proliferation and reducing apoptosis
- (2011) Xiaodong Han et al. BIOMEDICINE & PHARMACOTHERAPY
- Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats
- (2011) Luca D. Prisciandaro et al. CANCER BIOLOGY & THERAPY
- The impact of oral herpes simplex virus infection and candidiasis on chemotherapy-induced oral mucositis among patients with hematological malignancies
- (2011) Y.-K. Chen et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat
- (2011) Noor Al-Dasooqi et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Effect of Radiotherapy and Chemotherapy on the Risk of Mucositis During Intensity-Modulated Radiation Therapy for Oropharyngeal Cancer
- (2011) Giuseppe Sanguineti et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
- (2011) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral Adverse Events Associated with Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma: A Structured Literature Review
- (2011) C. B. Boers-Doets et al. ONCOLOGIST
- A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy
- (2011) Rajesh V. Lalla et al. SUPPORTIVE CARE IN CANCER
- Incidence and risk factors for lower alimentary tract mucositis after 1529 courses of chemotherapy in a homogenous population of oncology patients
- (2010) Somashekar G. Krishna et al. CANCER
- Serum levels of NF-κB and pro-inflammatory cytokines following administration of mucotoxic drugs
- (2010) Richard M Logan et al. CANCER BIOLOGY & THERAPY
- Cytokines levels, Severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer - a prospective pilot study
- (2010) Amichay Meirovitz et al. Radiation Oncology
- Regimen-related gastrointestinal toxicities in cancer patients
- (2010) Stephen T Sonis Current Opinion in Supportive and Palliative Care
- Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial
- (2009) Erik Skof et al. BMC CANCER
- Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib
- (2009) W.J. Lee et al. BRITISH JOURNAL OF DERMATOLOGY
- Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients
- (2009) Stephen Sonis et al. CANCER
- Chronic Radiation Enteritis
- (2009) V.S. Theis et al. CLINICAL ONCOLOGY
- Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial
- (2009) A. KAZEMIAN et al. EUROPEAN JOURNAL OF CANCER CARE
- The prevalence of chronic radiation enteritis following radiotherapy for cervical or endometrial cancer and its impact on quality of life
- (2009) J. Abayomi et al. European Journal of Oncology Nursing
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management
- (2009) Alexander Stein et al. Therapeutic Advances in Medical Oncology
- Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies
- (2008) Jens Benn Sorensen et al. CANCER
- Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis
- (2008) Narissa J. Nonzee et al. CANCER
- Role of Genetic and Nongenetic Factors for Fluorouracil Treatment-Related Severe Toxicity: A Prospective Clinical Trial by the German 5-FU Toxicity Study Group
- (2008) Matthias Schwab et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search